Hepion Pharmaceuticals Inc (NASDAQ: HEPA) Could Have Exceptional Returns?

In the last trading session, 5.78 million shares of the Hepion Pharmaceuticals Inc (NASDAQ:HEPA) were traded, and its beta was 1.63. Most recently the company’s share price was $0.11, and it changed around -$0.02 or -10.48% from the last close, which brings the market valuation of the company to $1.20M. HEPA currently trades at a discount to its 52-week high of $3.33, offering almost -2927.27% off that amount. The share price’s 52-week low was $0.12, which indicates that the current value has fallen by an impressive -9.09% since then.

Hepion Pharmaceuticals Inc stock received a consensus recommendation rating of Buy, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended HEPA as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Hepion Pharmaceuticals Inc is expected to report earnings per share of 0 for the current quarter.

Hepion Pharmaceuticals Inc (NASDAQ:HEPA) trade information

Instantly HEPA has showed a red trend with a performance of -10.48% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.1621 on recent trading dayincreased the stock’s daily price by 32.14%. The company’s shares are currently down -76.01% year-to-date, but still down -30.84% over the last five days. On the other hand, Hepion Pharmaceuticals Inc (NASDAQ:HEPA) is -39.55% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $70, which translates to bulls needing to increase their stock price by 99.84% from its current value. Analyst projections state that HEPA is forecast to be at a low of $70 and a high of $70.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 63.67%.